188 related articles for article (PubMed ID: 26885008)
21. Prognostic significance of serum tumor marker normalization in the perioperative period for patients with advanced gastric cancer.
Hu C; Zhang Y; Xu J; Chen W; Yu P; Wang Y; Bao Z; Zhang R; Xu Z; Cheng X
Ann Transl Med; 2022 Feb; 10(3):153. PubMed ID: 35284544
[TBL] [Abstract][Full Text] [Related]
22. [Early detection of non-palpable (T0) breast cancer: the diagnostic procedure for pathological discharge from the nipple].
Yayoi E; Furukawa J; Sekimoto M; Tateishi H; Kinuta M; Maruyama H; Okamura J
Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():133-9. PubMed ID: 8037475
[TBL] [Abstract][Full Text] [Related]
23. CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy.
Tong Y; Zhu Y; Zhao Y; Jiang C; Wang W; Shan Z; Sun F; Liu D; Zhang J
J Cancer; 2021; 12(21):6465-6472. PubMed ID: 34659537
[No Abstract] [Full Text] [Related]
24. Diagnostic potential of extracellular vesicle-associated microRNA-10b and tumor markers for lung adenocarcinoma.
Yuan G; Xie H; Wei T; Zhu D; Zhang C; Yang Y
Oncol Lett; 2021 Aug; 22(2):614. PubMed ID: 34257722
[TBL] [Abstract][Full Text] [Related]
25. Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid.
Lellé RJ; Henkel E; Leinemann D; Goeschen K
Gynecol Obstet Invest; 1989; 27(3):137-42. PubMed ID: 2737547
[TBL] [Abstract][Full Text] [Related]
26. Heat shock protein 90α in nipple discharge as a potential tumor marker for breast cancer.
Wang YY; Liu C; Chen X; Ji J; Zhu SL; Sun Q; Zhang K; Zhu J; Zhao S; Wang YW; Ma R; Wang JL
Chin J Physiol; 2021; 64(5):251-256. PubMed ID: 34708717
[TBL] [Abstract][Full Text] [Related]
27. Carcinoembryonic antigen estimation in nipple discharge as an adjunctive tool in the diagnosis of early breast cancer.
Inaji H; Yayoi E; Maeura Y; Matsuura N; Tominaga S; Koyama H; Takatsuka Y; Mori T
Cancer; 1987 Dec; 60(12):3008-13. PubMed ID: 3677024
[TBL] [Abstract][Full Text] [Related]
28. Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy.
Zhang Y; Zhao J; Wang Y; Cai W; Zhang X; Li K; Liu W; Zhao Y; Kang H
Dis Markers; 2022; 2022():7739777. PubMed ID: 35634442
[TBL] [Abstract][Full Text] [Related]
29. A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge.
Ge L; Liu G; Hu K; Huang K; Zhang M; Zhou J; Teng F; Cao J; Dai C; Jia X
Technol Cancer Res Treat; 2020; 19():1533033819901117. PubMed ID: 32167027
[TBL] [Abstract][Full Text] [Related]
30. Optimal cut-off values for tumor markers in cerebrospinal fluid with ROC curve analysis.
Shi Q; Pu CQ; Huang XS; Tian CL; Cao XT
Front Biosci (Elite Ed); 2011 Jun; 3(4):1259-64. PubMed ID: 21622132
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
Zheng H; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
[TBL] [Abstract][Full Text] [Related]
32. [Clinical usefulness of carcinoembryonic antigen measurement in nipple discharge as an adjunctive tool for diagnosis of breast cancer].
Nishiguchi T; Hishimoto T; Funahashi S; Takatsuka Y; Kawahara T
Rinsho Byori; 1992 Jan; 40(1):67-72. PubMed ID: 1545528
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of an improved dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge in early breast cancer: results of a multicenter study.
Mori T; Inaji H; Koyama H; Abe R; Nihei M; Izuo M; Ogawa T; Enomoto K; Sato H; Kasumi F
Jpn J Clin Oncol; 1992 Dec; 22(6):371-6. PubMed ID: 1291755
[TBL] [Abstract][Full Text] [Related]
34. Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC.
Zhao YS; Pang D; Wang F; Xue YW; Gao DN; Li H; Li K; Wang BY; Wang D; Li HY
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):732-8. PubMed ID: 19273481
[TBL] [Abstract][Full Text] [Related]
35. [Application of multiple tumor markers's protein chip in the screen program of the elderly].
Yan HY; Zhong RH; Li J; Luo XH; Chen R
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Sep; 32(9):924-6. PubMed ID: 22340884
[TBL] [Abstract][Full Text] [Related]
36. [The value of serum human tumor protein P53 in colorectal cancer combined diagnosis and postoperative monitoring].
Fan P; Zhang Y; Deng F; Chen SH; Li M; Zhang Q
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2670-2673. PubMed ID: 28910954
[No Abstract] [Full Text] [Related]
37. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis].
Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA.
Gao J; Zhang Q; Xu J; Guo L; Li X
Chin J Cancer Res; 2013 Dec; 25(6):743-8. PubMed ID: 24385703
[TBL] [Abstract][Full Text] [Related]
39. Study on the Effect and Application Value of Heat-Inactivated Serum on the Detection of Thyroid Function, Tumor Markers, and Cytokines During the SARS-CoV-2 Pandemic.
Xu E; Li T; Chen Q; Wang Z; Xu Y
Front Med (Lausanne); 2021; 8():742067. PubMed ID: 34733864
[No Abstract] [Full Text] [Related]
40. [Cancer clearance for "unprovoked" venous thromboembolism cases].
Ye W; Chen Y; Li M; Jiang C; Li D; Liu C
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(15):1143-6. PubMed ID: 24924711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]